Fatal familial insomnia: Sleep, neuroendocrine and vegetative alterations

https://doi.org/10.1016/0960-5428(94)00042-MGet rights and content

Abstract

Fatal Familial Insomnia (FFI) is an autosomal dominant prion disease, characterized by prominent degeneration of the thalamus and involving impaired control of the sleep-wake cycle and of autonomic and endocrine functions. Profound alterations in the sleep-wake cycle consist of progressive decrease or complete absence of sleep activity and loss of any intrinsic cyclic organization of residual sleep. Unbalanced sympathergic activation with preserved parasympathetic drive, associated with chronic secondary hypertension and loss of the physiological nocturnal decrease in blood pressure constitute the characteristic autonomic changes. Neuroendocrine studies document hypercortisolism with abnormal feed-back suppression of adrenocorticotrophic hormone, constantly elevated catecholamine levels and abnormal secretory patterns of growth hormone, prolactin and melatonin. Advanced stages of the disease are invariably characterized by the disappearance of any circadian autonomic and neuroendocrine rhythmicity.

FFI represents a model disease emphasizing the correlations among the different sleep, autonomic and neuroendocrine functions. Clinico-pathological correlations demonstrate the role of the thalamus as an integrative neural structure placed between the limbic system and the hypothalamus and controlling the homeostatic balance of the organism.

References (16)

  • P. Cortelli et al.

    Cardiovascular dysautonomia in fatal familial insomnia

    Clin. Autonom. Res.

    (1991)
  • L.G. Goldfarb et al.

    Fatal familial insomnia and familial Creutzfeldt-Jacob disease: disease phenotype determined by a DNA polymorphism

    Science

    (1992)
  • W.R. Hess

    Hypothalamus and Thalamus: Experimental Documentation

    (1969)
  • E. Lugaresi et al.

    Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei

    N. Engl. J. Med.

    (1986)
  • A. Lugaresi et al.

    Lack of vegetative and endocrine circadian rhythms in fatal familial thalamic degeneration

    Clin. Endocrinol.

    (1987)
  • E. Lugaresi et al.

    Thalamus, sleep, and circadian functions

  • V. Manetto et al.

    Fatal familial insomnia: clinical and pathologic study of five new cases

    Neurology

    (1992)
  • R. Medori et al.

    Fatal familial insomnia: a prion disease with a mutation at codon 178 of the prion protein gene

    N. Engl. J. Med.

    (1992)
There are more references available in the full text version of this article.

Cited by (35)

  • Fatal familial insomnia and the role of the thalamus in sleep regulation

    2011, Handbook of Clinical Neurology
    Citation Excerpt :

    Autonomic features can be seen to have a state-dependent modulation, sympathetic activity decreasing whenever short periods of SWS appear on the EEG. They are attended by increased plasma levels of catecholamines, such as norepinephrine and epinephrine, and are associated with endocrine changes with hypercortisolemia in the presence of normal or even low levels of adrenocorticotropic hormone (Portaluppi et al., 1994a; Montagna et al., 1995). Abnormal plasma levels of catecholamines and sympathetic activation are associated with loss of their circadian rhythmicity (Avoni et al., 1991) with, in particular, disruption of somatotropin secretion (Portaluppi et al., 1995).

  • Sleep, Breathing, and Neurologic Disorders

    2009, Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects: Third Edition
  • Sleep and Psychoneuroimmunology

    2009, Immunology and Allergy Clinics of North America
    Citation Excerpt :

    Mice devoid of the prion protein gene have alterations in circadian rhythms and sleep.38,39 Human fatal familial insomnia is characterized by profound alterations in sleep secondary to prion-induced degeneration of the thalamus.40 “Sleeping sickness,” perhaps the most notorious of infection-induced alterations in sleep, is caused by the protozoan Trypanosoma brucei.

  • Sleep, Breathing, and Neurologic Disorders

    2009, Sleep Disorders Medicine
View all citing articles on Scopus
View full text